Welcome to the Allos Media Center
where you will find the latest press releases
and FAQs.

Media Contacts

This contact information is for media professionals only. If you are not a member of the news media, please see the Contact Us section of this site.

Madeline Malia
Director, 
Public Relations
& Corporate Communications
mmalia@allos.com
609.454.0325
    Monique Greer
    Vice President,
    Corporate Communications
    & Investor Relations
    mgreer@allos.com
    720.540.5268

 

Press Releases

DATE TITLE
07/28/10 Allos Therapeutics Reports Second Quarter 2010 Financial Results
07/28/10 Allos Therapeutics Announces Topline Results from Phase 2b Study of FOLOTYN in Patients with Advanced Non-Small Cell Lung Cancer
07/12/10 Allos Therapeutics to Report Second Quarter 2010 Financial Results on July 28, 2010
06/17/10 Allos Therapeutics' Pralatrexate Granted Orphan Medicinal Product Designation for the Treatment of Cutaneous T-Cell Lymphoma by the European Commission
06/11/10 Allos Therapeutics' FOLOTYN Shows Activity and Tolerability in Phase 1 Dose Finding Study in Patients with Relapsed or Refractory CTCL

Media FAQs

Where is Allos incorporated?
Where is Allos headquartered?
How many employees are at Allos?
When did Allos go public?
Do you have b-roll footage available?
On which exchange is Allos listed and what is the ticker symbol?

 

Where is Allos incorporated?
Allos is incorporated in the state of Delaware.

Where is Allos headquartered?
Allos is headquartered in Westminster, CO.

How many employees are at Allos?
Allos currently has approximately 180 employees.

When did Allos go public?
Allos completed an initial public offering in March 2000.

Do you have b-roll footage available?
Yes, we have broadcast-quality b-roll footage available for journalists upon request.

On which exchange is Allos listed and what is the ticker symbol?
Allos common stock is listed on the NASDAQ Global Market under the symbol ALTH.